The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst, page-1018

When it comes to PAA , I’m not being particularly altruistic, I’m here to make some money, and pleased to be involved with a drug that will dramatically improve the lives of so many at the same time.

I know there is a due process that must be followed, even going off script a little can result in heartbreak ( eg. Relyvrio ), but when I read a comment like the one below, and can see what a difference MPL is making to 12 lives with ALS, I just wish there was a way to expedite the market release … what have they to lose, there is NO options on offer, a meagre couple of months at best.


I can only hope for this individual that they are fortunate to get onto the MPL phase 2 / 3 trial.

Lets hope for great reads on the 12 patients on the OLE study, ODD sooner than expected and that the phase 2 study does get underway in the timeline MT is working towards ( as ridiculously tight as it is ).